MyOme’s Post

Precision medicine is revolutionizing healthcare with personalized treatments based on genetic insights. By considering individual genes, environment, and lifestyle, it offers accurate strategies for treatment and prevention. Online collaborations, investments, and advances in cancer biology drive market growth. It's proactive healthcare at its best! 💡💊 Read more https://lnkd.in/g9tdYveU #precisionmedicine #personalizedmedicine #genomics #healthcareinnovation #medicalresearch #biotechnology #marketresearch #marketanalysis #precisiononcology #healthtech #industryinsights #markettrends #consumerresearch #businessintelligence #patientcare #precisiontherapeutics

🧬𝗥𝗲𝗰𝗲𝗻𝘁 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗟𝗮𝘂𝗻𝗰𝗵𝗲𝘀🧬 MESO SCALE DIAGNOSTICS, LLC. has launched the new U-PLEX CAR-T Cell Combos that are related to key aspects of CAR-T cell biology. The new Combos focus on CAR-T Cell Exhaustion and Safety and complement two existing Combos that are part of the U-PLEX portfolio. Eclipsebio has launched its eRibo Pro service to identify differential transcription and translation as well as high-resolution mapping of ribosome positioning. Element Biosciences has launched Aviti Fit, a suite of products to provide more flexibility on its Aviti instrument. Precipio, Inc. has launched its Quantitative BCR-ABL 2.0 panel for confirming chronic myeloid leukaemia (CML) diagnosis. #immunoassay #multiplex #cart #haematology #diagnostics #sequencing #rna #genomics #transcriptomics

Liquid biopsies enable the study of the molecules present in our circulation. Blood is composed of many cell types, but it is also the carrier of biological information such as cell-free RNA (cfRNA). Because all tissues shed RNA into the circulation, liquid biopsies are the perfect snapshot of what is happening to all organs at a specific time, from a single blood draw. At Flomics, we know that cfRNAs are highly accurate biomarkers, allowing reliable diagnosis of complex diseases, even before the first symptoms appear. #biotech #bioinformatics

🔬 Exciting Update in the World of Healthcare! Join me at [Advances in Molecular Diagnostics & Precision Medicine] for a deep dive into Molecular Diagnostics and Precision Medicine. 🌐 📅 Date: [August 12–13] 📍 Location: [Rome, Italy] 🚀 Explore groundbreaking advancements, connect with industry leaders, and stay at the forefront of healthcare innovation. Don't miss out on the future of personalized medicine! 🔗Website: https://lnkd.in/gUXStGxE Molecular Diagnostics & Precision Medicine See you there! #rome #italy #event #molecularbiology #moleculardiagnostics #proteomics #dna #rna #rnatherapeutics #mutations #microfluidics #genetictesting #genomics #genomicmedicine #pcr #pharmacogenetics #protein #genetics #precisionmedicine #pharmacogenomics #artificialintelligence #clinicaltrials #researchers #therapeutics #pathology #biomedical #bioinformatics #massspectrometry #nutrigenomics #pcr #mutation #pathogens #biomedicalresearch #digitalpathology #sciinovgroup #MDPM2024

🔬 Exciting Update in the World of Healthcare! Join me at [Advances in Molecular Diagnostics & Precision Medicine] for a deep dive into Molecular Diagnostics and Precision Medicine. 🌐 📅 Date: [August 12–13] 📍 Location: [Rome, Italy] 🚀 Explore groundbreaking advancements, connect with industry leaders, and stay at the forefront of healthcare innovation. Don't miss out on the future of personalized medicine! 🔗Website: https://lnkd.in/gUXStGxE Molecular Diagnostics & Precision Medicine See you there! #rome #italy #event #molecularbiology #moleculardiagnostics #proteomics #dna #rna #rnatherapeutics #mutations #microfluidics #genetictesting #genomics #genomicmedicine #pcr #pharmacogenetics #protein #genetics #precisionmedicine #pharmacogenomics #artificialintelligence #clinicaltrials #researchers #therapeutics #pathology #biomedical #bioinformatics #massspectrometry #nutrigenomics #pcr #mutation #pathogens #biomedicalresearch #digitalpathology #sciinovgroup #MDPM2024

Calling all researchers passionate about advancing ALS therapeutics! Our Basic Biology Consortia is now accepting Letters of Interest (LOIs) to unravel the mysteries of sporadic ALS and identify novel therapeutic targets. Did you know that despite progress in genetic ALS therapies, a staggering 90% of ALS patients still await new treatment options? Join us in the quest to address this unmet need by delving into the fundamental biology of the disease. Your research could be the key to unlocking the next wave of therapeutic possibilities! Ready to make a significant impact? Start the application process now >> https://lnkd.in/erFmqNbU #ALSResearch #GrantOpportunity #sporadicALS

Exited to share that we have sponsored and attended an insightful one day seminar on Medical Entrepreneurship organized by the Research & Development Wing, Sree Balaji Medical College And Hospital. Thanks to the organizing committee and our special thanks to Dr. Kalaivani M.K Dr. venkatesh Babu Dr. rajni Devi Pallavi Rao for their unconditional support in making it successful. #medicalentrepreneurship #genetics #genomics #translationalresearch #ngs #precisiongenomics #pharmacogenomics #diagnostics #clinicalresearch #clinicalgenomics #preventivegenomics

Genetics is the new frontier of healthcare, and #Genes2Me is your one-stop solution for next generation sequencing tools. We provide a whole range of focused 27+ CE-IVD marked #NGS Clinical Panels compatible with #Illumina, Thermofisher and MGI platforms. The panels are designed for accurate #diagnosis of a variety of #genetic and somatic #cancers, cardiovascular, respiratory and neurological disorders which aid in the prevention as well as timely treatment of the patient. Our NGS clinical #panels are complemented with cloud-based automated data analysis #software called #CliSeq Interpreter. https://lnkd.in/gmvpbZz2 #nextgenerationsequencing #bioinformatics #genomics #ngspanels #analysis #sequencing #research #liquidbiopsy #ngsanalysis #genomics #biotech #biotechnology #bioinformatics #yearsofexcellence #data #bioindia #dna #rna #liquidbiopsy #sequencing #genome #genomeanalysis #molecularbiology #g2m

Every year, the last day of February marks rare disease day. Across the globe, over 6000 different rare diseases have been identified, impacting approximately 300 million individuals. With a deepening understanding of the biology of rare diseases and the rapid advancement of novel therapies, an increasing number of enterprises and institutions are contributing to research and development in this field. WuXi Biology offers integrated services for rare disease drug research, from the generation and characterization of animal models to colony management and pre-clinical pharmacology research. Our platform encompasses numerous rare diseases, including hematologic, metabolic, immunologic, and neurologic diseases. #RareDiseases #RareDiseaseDay #RareDiseaseDay2024 #Biotech #DrugDiscovery #DrugDevelopment

Nature creates the most effective medicine, but how it does so is still being actively understood. A discovery of the two enzymes behind the encoding of tiancimycin A may have just unlocked a key understanding of how potent natural anti-cancer compounds are formed. “Even after we identified genes responsible for encoding tiancimycin A, several of the steps required to synthesize it could not be predicted,” Gui said. “The two enzymes described in the current study are highly unusual.” https://lnkd.in/gC5AAhFN #medicine #medicalindustry #cancerprevention #cancerfighters #naturalmedicine #innovation